Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells

Molecular and Cellular Biology

Volumn 16, Issue 11, 1996, Pages 6427-6435

  Huang, Chuanshu ^a   Ma, Wei Ya ^a   Dong, Zigang ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR AP 1; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; MALIGNANT TRANSFORMATION; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ANIMALIA; MURINAE;

EID: 0029843344     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.11.6427     Document Type: Article

References (54)

1. Alani, R., P. Brown, B. Binetruy, H. Dosaker, R. K. Rosenberg, P. Angel, M. Karin, and M. J. Birrer. 1991. The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells. Mol. Cell. Biol. 11:6286-6295.
2. Auger, K. R., L. A. Serunian, S. P. Soltoff, P. Libby, and L. C. Cantley. 1989. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57:167-175.
3. Baserga, R. 1995. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55:249-252.
4. Cantley, L. C., K. R. Auger, C. Carpenter, B. Duckworth, A. Graziani, R. Kapeller, and S. Soltoff. 1991. Oncogenes and signal transduction. Cell 64:281-302. (Erratum, 65:5.)
5. Carpenter, C. L., B. C. Duckworth, K. R. Auger, B. Cohen, B. S. Schaffhausen, and L. C. Cantley. 1990. Purification and characterization of phosphoinositide 3-kinase from rat liver. J. Biol. Chem. 265:19704-19711.
6. Cohen, B., Y. Liu, B. Drucker, T. M. Roberts, and B. S. Schaffhausen. 1990. Characterization of pp85, a target of oncogenes and growth factor receptors. Mol. Cell. Biol. 10:2909-2915.
7. Colburn, N. H., E. J. Wendel, and G. Abruzzo. 1981. Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion. Proc. Natl. Acad. Sci. USA 78:6912-6916.
8. Coppola, D., A. Ferberg, M. Miura, C. Sell, C. D'Ambrosio, R. Rubin, and R. Baserga. 1994. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol. Cell. Biol. 14:4588-4595.
9. Cross, M. J., A. Stewart, M. N. Hodgkin, D. J. Kerr, and M. J. O. Wakelam. 1995. Wortmannin and its structural analogue demethoxyviridin inhibit stimulated phospholipase A2 activity in Swiss 3T3 cells. J. Biol. Chem. 270: 25352-25355.
10. Domann, F. E., J. P. Levy, M. J. Birrer, and G. T. Bowden. 1994. Stable expression of a c-Jun deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Differ. 5:9-16.
11. Dong, Z. G., M. J. Birrer, R. G. Walts, L. M. Matrisian, and N. H. Colburn. 1994. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl. Acad. Sci. USA 91:609-613.
12. Dong, Z. G., V. Lavrovsky, and N. H. Colburn. 1995. Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis 16:749-756.
13. Dong, Z. G., R. G. Watts, Y. Sun, S. N. Zhan, and N. H. Colburn. 1995. Progression elevation of AP-1 activity during preneoplastic-to-neoplastic progression as modeled in JB6 cell variants. Int. J. Oncol. 7:359-364.
14. Downes, C. P., and A. N. Carter. 1991. Phosphoinositide 3-kinase: a new effector in signal transduction? Cell Signal 3:501-513.
15. Endemann, G., K. Yonezawa, and R. A. Roth. 1990. Phosphatidylinositol kinase or an associated protein is a substrate fur the insulin receptor tyrosine kinase. J. Biol. Chem. 265:396-400.
16. Fukui, Y., A. R. Saltiel, and H. Hanafusa. 1991. Phosphatidylinositol-3 kinase is activated in v-src, v-yes, and v-fps transformed chicken embryo fibroblasts. Oncogene 6:407-411.
17. Gabbay, R. A., C. Sutherland, L. Gnudi, B. B. Kahn, R. M. O'Brien, D. K. Granner, and J. S. Flier. 1996. Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogcn-activated protein kinase signaling pathway. J. Biol. Chem. 271:1890-1897.
18. Hare, K., K. Yonezawa, H. Sakaue, A. Ando, K. Kotani, T. Kitamura, Y. Kitamura, H. Ueda. L. Stephens, T. R. Jackson, P. T. Hawkins, R. Dhand, A. E. Clark, G. D. Holman, M. D. Waterfield, and M. Kasuga. 1994. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc. Natl. Acad. Sci. USA 91:7415-7419.
19. Hawkins, P. T., T. R. Jackson, and L. R. Stephens. 1992. Platelet-derived growth factor stimulates synthesis of PtdIns(3,4,5)P3 by activating a PtdIns(4,5)P2 3-OH kinase. Nature (London) 358:157-159.
20. Hongo, A., C. D'Ambrosio, M. Miura, A. Morrione, and R. Baserga. 1996. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene 12:1231-1238.
21. Hu, Q., A. Klippel, A. J. Muslin, W. J. Fantl, and L. T. Williams. 1995. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 286:100-102.
22. Huang, C. S., W. Y. Ma, and Z. G. Dong. 1996. Inhibitory effects of ascorbic acid on AP-1 activity and transformation of JB6 cells. Int. J. Oncol. 8:389-393.
23. Jhun, B. H., D. W. Rose, B. L. Seely, L. Rameh, L. Cantley, A. R. Saltiel, and J. M. Olefsky. 1994. Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression. Mol. Cell. Biol. 14:7466-7475.
24. Joly, M., A. Kazlauskas, F. S. Fay, and S. Corvera. 1994. Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science 263:684-687.
25. Lavrovsky, V., Z. G. Dong, W. Y. Ma, and N. Colburn. 1996. Drug induced reversion of progression phenotype is accompanied by reversion of AP-1 phenotype in JB6 cells. In Vitro Cell. Dev. Biol. 32:234-237.
26. Levy-Toledano, R., D. H. Blaettler, W. J. Larochelle, and S. I. Taylor. 1995. Insulin-induced activation of phosphatidylinositol (PI) 3-kinase. J. Biol. Chem. 270:30018-30022.
27. Li, J. J., Z. Dong, G. Hegamyer, M. Dawson, and N. Colburn. 1996. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res. 56:483-489.
28. Matrisian, L. M., S. McDonnell, D. B. Miller, M. Navke, E. A. Seftor, and M. J. C. Hend. 1991. The role of the matrix methalloproteinase stromelysin in the progression of squamous cell carcinomas. Am. J. Med. Sci. 302:157-162.
29. Miura, M., E. Surmacz, J. L. Burgaud, and R. Baserga. 1995. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J. Biol. Chem. 270:22639-22644.
30. Rodriguez-Viciana, P., P. H. Warne, R. Dhand, B. Vanhaesebroeck, I. Gout, M. J. Fry, M. D. Waterfield, and J. Downward. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature (London) 370:527-532.
31. Rodriguez-Viciana, P., P. H. Warne, B. Vanhaesebroeck, M. D. Waterfield, and J. Downward. 1996. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J. 15:2442-2451.
32. Sakaue, H., K. Hara, T. Noguchi, T. Matozaki, K. Kotani, W. Ogawa, K. Yonezawa, M. D. Waterfield, and M. Kasuga. 1995. Ras-independent and wortmannin-sensitive activation of glycogen synthase by insulin in Chinese hamster ovary cells. J. Biol. Chem. 270:11304-11309.
33. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. p. 9.16-9.58. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
34. Schaffer, L. 1994. A model for insulin binding to the insulin receptor. Eur. J. Biochem. 24:1127-1132.
35. Sell, C., G. Dumenil, C. Deveaud, M. Miura, O. Coppola, T. DeAngelis, R. Rubin, A. Efstratiadis, and R. Baserga. 1994. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol. 14:3604-3612.
36. Sell, C., M. Rubini, R. Rubin, J.-P. Liu, A. Etstratiadis, and R. Baserga. 1993. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor. Proc. Natl. Acad Sci. USA 90:11217-11221.
37. Sjolander, A., and E. C. Lapentina. 1992. Agonist-induced association of the p21ras GTPase-activating protein with phosphatidylinositol 3-kinase. Biochem. Biophys. Res. Commun. 189:1503-1508.
38. Sjolander, A., K. Yamamoto, B. E. Huber, and E. C. Lapetina. 1991. Association of p21ras with phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 88:7908-7912.
39. Stephens, L. R., K. T. Hughes, and R. F. Irvine. 1991. Pathway of phosphatidylinositol(3,4,5)-trisphosphate synthesis in activated neutrophils. Nature (London) 351:33-39.
40. Stephens, L. R., T. R. Jackson, and P. T. Hawkins. 1993. Agonist-stimulated synthesis of phosphatidylinositol (3,4,5)-trisphosphate: a new intracellular signalling system? Biochim. Biophys. Acta 1179:27-75.
41. Surmacz, E., C. Sell, J. Swartek, H. Kato, C. T. Roberts, D. Leroith, and R. Baserga. 1995. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor. Exp. Cell Res. 218:3711-380.
42. Tartare, S., I. Mothe, A. Kowalski-Chauvel, J.-P. Breittmayer, R. Ballotti, and E. Van Obberghen. 1994. Signal transduction by a chimeric insulin-like growth factor-1 (IGF-1) receptor having the carboxyl-terminal domain of the insulin receptor. J. Biol. Chem. 269:11449-11455.
43. Thelen, M., M. P. Wymann, and H. Langen. 1994. Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes. Proc. Natl. Acad. Sci. USA 91:4960-4964.
44. Traynor-Kaplan, A. E., A. Harris, B. Thompson, P. Taylor, and L. A. Sklar. 1988. An inositol tetrakisphosphate-containing phospholipid in activated neutrophils. Nature (London) 334:353-356.
45. Urich, M., M. Y. M. E. Shemerly, D. Besser, Y. Nagamine, and K. Ballmer-Hofner. 1995. Activation and nuclear translocation of mitogen-activated protein kinases by polyomavirus middle-T or serum depend on phosphatidylinositol 3-kinase. J. Biol. Chem. 270:29286-29292.
46. Valentinis, B., P. L. Porcu, K. Quinn, and R. Baserga. 1994. The role of the insulin-like growth factor I receptor in the transformation by simian virus 40 T antigen. Oncogene 9:825-831.
47. Varticovski, L., G. Q. Daley, P. Jackson, D. Baltimore, and L. C. Cantley. 1991. Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants. Mol. Cell. Biol. 11:1107-1113.
48. Vlahos, C. J., W. F. Mather, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241-5248.
49. 2 complex. Mol. Cell. Biol. 15:2791-2799.
50. Weinstein, B. 1988. The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment - twenty-seventh G.H.A. Clowes Memorial Award lecture. Cancer Res. 48: 4135-4143.
51. Weinstein, B. 1991. Mitogenesis is only one factor in carcinogenesis. Science 251:387-388.
52. Whitman, M., C. P. Downes, M. Keeler, T. Keller, and L. Cantley. 1988. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature (London) 332:644-646.
53. 1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein. Cell Growth Differ. 6:1225-1234.
54. Yano, H., S. Nakanishi, K. Kimura, N. Hanai, Y. Saitoh, Y. Fukui, Y. Nonomura, and Y. Matsuda. 1993. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:25846-25856.